摘要糖尿病黄斑水肿(DME)是糖尿病患者常见眼部的并发症,病变主要累及与视功能密切相关的黄斑区,是导致患者视力损伤甚至致盲的主要原因之一.如何减轻DME对患者视功能带来的危害始终是眼科界的难点.近三十年来,针对DME的治疗经历了从激光光凝、抗炎治疗到抗VEGF治疗的发展过程.然而,DME的发生发展机制尚不完全清楚,现有的各种治疗方式有其自身的优点和不足之处.所以,DME治疗还是富有挑战的未尽探索.尽管如此,通过大家的不懈努力,逐渐减轻DME的视功能危害仍然是曙光在望.

abstractsDiabetic macular edema (DME) is a common ocular complication of diabetes patients.It mainly involve macular which is closely related with visual function,thus DME is one of the major reasons causing visual impairment or blindness for diabetes patients.How to reduce the visual damage of DME is always a big challenge in the ophthalmic practice.In the past three decades,there are tremendous developments in DME treatments,from laser photocoagulation,anti-inflammation drugs to anti-vascular endothelial growth factor therapy.However,the mechanism of DME development is not yet completely clear; every existing treatment has its own advantages and weaknesses.Therefore DME treatment still challenges us to explore further to reduce the DME damages.